$2.93-5.48%
2026-10-06 closeSAB Biotherapeutics's published financial data is dated 2026-10-04. 2024 revenue was $1M. 2024 operating profit was −$43M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy
SAB Biotherapeutics's published financial data is dated 2026-10-04. 2024 revenue was $1M. 2024 operating profit was −$43M.